Safety and Efficacy of Novel Incretin Co-agonist Cotadutide in Biopsy-proven Noncirrhotic MASH With Fibrosis

Authors:

Abstract
No abstract available
Funding Information
  • Gilead Sciences
  • Novartis
  • AstraZeneca

This publication has 25 references indexed in Scilit: